Stocks
Affimed (AFMD) EBITDA US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, € | ? | -30 972 000 | -40 231 161 | -55 421 787 | -81 473 000 | -102 380 000 | -65 187 000 | ||
| Changes by years, y/y, % | +64% | +30% | +38% | +47% | +26% | +40.2% | |||
Affimed. EBITDA US GAAP, €
Affimed. EBITDA US GAAP, changes, %
Affimed. EBITDA US GAAP, sum by quarters, €
Affimed (AFMD) EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | LTM ? | |||
| EBITDA, € | ? | -23 191 757 | -19 317 000 | -16 722 000 | -14 702 000 | -14 446 000 | -65 187 000 | |
| Changes by years, y/y, % | +48% | -38% | -46% | -49% | -38% | |||
| Changes by quarters, q/q, % | -19% | -17% | -13% | -12% | -2% | |||
